HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2016

Conditions
Mental and Behavioral Disorders Due to Harmful Drug Use
Interventions
BEHAVIORAL

HealthCall and Motivational Interviewing

Patients access HealthCall by calling a toll-free number and putting a four-digit Personal Identification Number (PIN). The HealthCall system will then ask a short script of pre-recorded questions in English or Spanish, on substance use and other variables (e.g., medication adherence, unprotected sex, feeling of physical well-being, stress, etc). The MI session focuses on reduce ambivalence and increase motivation to reduce non-injection drug use (NIDU), gain a commitment to change, if possible, and ultimately to reduce or eliminate NIDU. The intervention includes: a) identifying pros and cons of using and stopping; b) exploring ambivalence about stopping NIDU; c) eliciting change talk

BEHAVIORAL

Motivational Interviewing (MI)

The MI session focuses on reduce ambivalence and increase motivation to reduce non-injection drug use (NIDU), gain a commitment to change, if possible, and ultimately to reduce or eliminate NIDU. The intervention includes: a) identifying pros and cons of using and stopping; b) exploring ambivalence about stopping NIDU; c) eliciting change talk

BEHAVIORAL

HIV/AIDS health education

The purpose of this condition is to control for clinical attention associated with Motivational Interviewing (MI)participation, and to provide an analogue of standard care, i.e. brief advice but no other intervention.

Trial Locations (2)

10019

Mt Sinai Spencer Cox Center for Health, New York

10032

Institute for Advanced Medicine, Mt. Sinai services, New York

All Listed Sponsors
lead

Research Foundation for Mental Hygiene, Inc.

OTHER

NCT01312181 - HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics | Biotech Hunter | Biotech Hunter